AU2001271785A1 - Combinations of statins, estrogenic agents and optionally estrogens - Google Patents
Combinations of statins, estrogenic agents and optionally estrogensInfo
- Publication number
- AU2001271785A1 AU2001271785A1 AU2001271785A AU7178501A AU2001271785A1 AU 2001271785 A1 AU2001271785 A1 AU 2001271785A1 AU 2001271785 A AU2001271785 A AU 2001271785A AU 7178501 A AU7178501 A AU 7178501A AU 2001271785 A1 AU2001271785 A1 AU 2001271785A1
- Authority
- AU
- Australia
- Prior art keywords
- statins
- combinations
- estrogenic agents
- estrogens
- optionally
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21609600P | 2000-07-06 | 2000-07-06 | |
| US21618400P | 2000-07-06 | 2000-07-06 | |
| US60/216,184 | 2000-07-06 | ||
| US60/216,096 | 2000-07-06 | ||
| PCT/US2001/021085 WO2002003977A2 (en) | 2000-07-06 | 2001-06-29 | Combinations of statins, estrogenic agents and optionally estrogens |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001271785A1 true AU2001271785A1 (en) | 2002-01-21 |
Family
ID=26910656
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001271785A Abandoned AU2001271785A1 (en) | 2000-07-06 | 2001-06-29 | Combinations of statins, estrogenic agents and optionally estrogens |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1359940A2 (en) |
| JP (1) | JP2004502731A (en) |
| CN (1) | CN1468110A (en) |
| AU (1) | AU2001271785A1 (en) |
| BR (1) | BR0112365A (en) |
| CA (1) | CA2414060A1 (en) |
| MX (1) | MXPA02012896A (en) |
| WO (1) | WO2002003977A2 (en) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7396855B2 (en) | 2002-07-24 | 2008-07-08 | Children's Hospital Medical Center | Compositions and products containing S-equol, and methods for their making |
| WO2004039327A2 (en) | 2002-10-29 | 2004-05-13 | Colorado State University Research Foundation | Use of equol for treating androgen mediated diseases |
| US8668914B2 (en) | 2002-07-24 | 2014-03-11 | Brigham Young University | Use of equol for treating skin diseases |
| US8580846B2 (en) | 2002-10-29 | 2013-11-12 | Brigham Young University | Use of equol for ameliorating or preventing neuropsychiatric and neurodegenerative diseases or disorders |
| US7781478B2 (en) | 2004-07-14 | 2010-08-24 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
| HUE055321T2 (en) | 2015-10-01 | 2021-11-29 | Olema Pharmaceuticals Inc | Tetrahydro-1h-pyrido[3,4-b]indole anti-estrogenic drugs |
| JP6920709B2 (en) | 2015-12-09 | 2021-08-18 | ザ・ボード・オブ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・イリノイＴｈｅ Ｂｏａｒｄ Ｏｆ Ｔｒｕｓｔｅｅｓ Ｏｆ Ｔｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｉｌｌｉｎｏｉｓ | Benzothiophene-based selective estrogen receptor down regulator |
| WO2017197046A1 (en) | 2016-05-10 | 2017-11-16 | C4 Therapeutics, Inc. | C3-carbon linked glutarimide degronimers for target protein degradation |
| CN109562113A (en) | 2016-05-10 | 2019-04-02 | C4医药公司 | Loop coil degron body for target protein degradation |
| EP3454856A4 (en) | 2016-05-10 | 2019-12-25 | C4 Therapeutics, Inc. | Heterocyclic degronimers for target protein degradation |
| JP2019520379A (en) | 2016-07-01 | 2019-07-18 | ジー１ セラピューティクス， インコーポレイテッド | Pyrimidine antiproliferative agents |
| WO2018081168A2 (en) | 2016-10-24 | 2018-05-03 | The Board Of Trustees Of The University Of Illinois | Benzothiophene-based selective mixed estrogen receptor downregulators |
| WO2018129387A1 (en) | 2017-01-06 | 2018-07-12 | G1 Therapeutics, Inc. | Combination therapy for the treatment of cancer |
| CA3052810A1 (en) | 2017-02-10 | 2018-08-16 | G1 Therapeutics, Inc. | Benzothiophene estrogen receptor modulators |
| CN110913861B (en) | 2017-06-29 | 2024-01-09 | G1治疗公司 | Morphological forms of G1T38 and methods of making the same |
| WO2020132561A1 (en) | 2018-12-20 | 2020-06-25 | C4 Therapeutics, Inc. | Targeted protein degradation |
| WO2024030968A1 (en) | 2022-08-03 | 2024-02-08 | Brystol-Myers Squibb Company | Compounds for modulating ret protein |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU3894299A (en) * | 1998-05-15 | 1999-12-06 | American Home Products Corporation | Compositions comprising 2-phenyl-indole compounds and estrogen formulations |
| AP1424A (en) * | 1998-05-15 | 2005-06-06 | Wyeth Corp | 2-Phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole in combination with estrogens. |
-
2001
- 2001-06-29 CA CA002414060A patent/CA2414060A1/en not_active Abandoned
- 2001-06-29 MX MXPA02012896A patent/MXPA02012896A/en unknown
- 2001-06-29 EP EP01950826A patent/EP1359940A2/en not_active Withdrawn
- 2001-06-29 JP JP2002508432A patent/JP2004502731A/en active Pending
- 2001-06-29 WO PCT/US2001/021085 patent/WO2002003977A2/en not_active Application Discontinuation
- 2001-06-29 AU AU2001271785A patent/AU2001271785A1/en not_active Abandoned
- 2001-06-29 BR BR0112365-3A patent/BR0112365A/en not_active IP Right Cessation
- 2001-06-29 CN CNA018150896A patent/CN1468110A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| BR0112365A (en) | 2003-05-13 |
| EP1359940A2 (en) | 2003-11-12 |
| JP2004502731A (en) | 2004-01-29 |
| CN1468110A (en) | 2004-01-14 |
| WO2002003977A2 (en) | 2002-01-17 |
| WO2002003977A3 (en) | 2003-09-04 |
| CA2414060A1 (en) | 2002-01-17 |
| MXPA02012896A (en) | 2003-10-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001273125A1 (en) | Combinations of bisphosphonates, estrogenic agents and optionally estrogens | |
| AU2001273569A1 (en) | Perfluoropolyethers and processes therefor and therewith | |
| AU2001258341A1 (en) | 8beta-hydrocarbyl-substituted estratrienes for use as selective estrogens | |
| AU2001271785A1 (en) | Combinations of statins, estrogenic agents and optionally estrogens | |
| AU2001280599A1 (en) | Compounds and methods | |
| AU2001286301A1 (en) | Garbage deodorizing and dedhydrating apparatus | |
| AU2001280801A1 (en) | Mixer and process for use | |
| AU2001294549A1 (en) | Process and intermediates | |
| EP1151667A3 (en) | Plant-activating agent | |
| AU2001273074A1 (en) | Combinations of ssri and estrogenic agents | |
| AU2001233208A1 (en) | Human sulfatases | |
| AU2001243394A1 (en) | Compounds and methods | |
| EP1144431A3 (en) | 16-hydroxyestratrienes as selective estrogens | |
| AU2001292936A1 (en) | Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines | |
| AU2002243386A1 (en) | Rf2a and rf2b transcription factors | |
| AU2001231155A1 (en) | Microbes and methods for remediation | |
| IL149715A0 (en) | MICROBIAL 9α-HYDROXYLATION OF STEROIDS | |
| AUPQ872300A0 (en) | Compounds and methods | |
| AU2001295185A1 (en) | Multiplexing-interleaving and demultiplexing-deinterleaving | |
| AU2001233932A1 (en) | Method and composition | |
| AU2001278951A1 (en) | Compounds and methods | |
| AU4432001A (en) | Trityl-type compounds and their use | |
| AU2001266689A1 (en) | 4-benzyl-2-hydroxy-1,4-oxazin-3-one and polymorphic forms thereof | |
| AU2002239775A1 (en) | Chemical-library composition and method | |
| AU2092200A (en) | Use of estrogens and delta-gonadien-21-ol-3,20-diones |